VYLOMA
VYLOMA
Approved
DIN Number
02365561
Drug Class
Human
Market Date
Apr 19, 2011
Company
HC
bausch health, canada inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02365561
AIG Number0135820002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
D06BB10 IMIQUIMOD
Product Specifications
Dosage FormCream
Route of AdministrationTopical
AHFS Classification84:92.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
IMIQUIMODActive
Strength: 3.75 % / W/W
Monograph: IMIQUIMOD
